AzTrials
AzTrials

Mandibular PrognathismNCT04629859

Orthognathic Surgeries and Pharyngeal Airway Space

A study testing mandibular setback and maxillary advancement and mandibular setback in people with Mandibular Prognathism, run by Fayoum University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

twenty-four patients with dentoskeletal deformity of class III will be divided equally into two groups and will be subjected to orthognathic surgeries group A; will be treated by mandibular setback surgery while group B will be treated with bimaxillary orthognathic surgery in the form of mandibular setback and… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mandibular Prognathism
What is being tested?
mandibular setback and maxillary advancement and mandibular setback
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteEgypt
Study dates
1 Jan 2020to 1 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • dento-skeletal class III malocclusion which needed a surgical intervention with maxillary advancement surgery and/or mandibular set-back orthognathic surgery in the form of bilateral sagittal split osteotomy
  • no previous orthognathic surgery

Who cannot join

  • Patients with craniofacial syndromes.
  • Medically compromised patients and patients with bone anomalies

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Fayoum University

    Al Fayyum

Other trials in Egypt

About this study

Official title: Malocclusion Patients

twenty-four patients with dentoskeletal deformity of class III will be divided equally into two groups and will be subjected to orthognathic surgeries group A; will be treated by mandibular setback surgery while group B will be treated with bimaxillary orthognathic surgery in the form of mandibular setback and maxillary advancement surgeries. the total pharyngeal airway will be measured on lateral cephalometric radiographs, integrating retro-palatal and retro-glossal area, and statistically will be compared preoperative, immediate postoperative, and at 6 months post-surgically

Being tested
mandibular setback and maxillary advancement, mandibular setback
Keywords
Orthognathic surgery, Pharyngeal airway space, skeletal class III patients.
Medical subject headings
Malocclusion, Angle Class III

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mandibular setback and maxillary advancementProcedure or surgery

    12 patients will undergo mandibular setback and maxillary advancement

  • mandibular setbackProcedure or surgery

    12 patients will undergo mandibular setback

Study groups in NCT04629859
Study groupRoleWhat they receive
study armExperimentaldento skeletal class III patients will undergo a mandibular setback surgery and maxillary advancement
Receives: Procedure: mandibular setback and maxillary advancement
controlled armExperimentaldento skeletal class III patients will undergo a mandibular setback surgery
Receives: Procedure: mandibular setback

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. total pharyngeal airway space surface area

    Cephalometric analyses will be performed, the pharyngeal airway is demarcated inferiorly by a line passing through the tip of epiglottis and the superior tip of the hyoid bone, namely Line A, while the retro-glossal and the retro-palatal airway is separated by a line extending from the basion parallel to line A.

    All the reference points and lines were conveyed to the images . The Pharyngeal airway space was measured and compared.

    Measured: 6 months

Secondary outcomes (1)
  1. Epworth sleepiness scale

    (0-24) score to assess sleep apnea indirect

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Nov 2020
  2. Study start1 Jan 2020
  3. Primary completion30 Nov 2020
  4. Study completion1 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04629859
Sponsor's protocol ID
12/10/19
Status last verified
Aug 2023
First submitted
11 Nov 2020
Last updated
7 Aug 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing mandibular setback and maxillary advancement and mandibular setback in people with Mandibular Prognathism, run by Fayoum University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

total pharyngeal airway space surface area (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in